Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer

被引:146
|
作者
Xue, Mei [1 ]
Chen, Wei [2 ]
Li, Xu [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Translat Med, 277 West Yanta Rd, Xian 710061, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Clin Lab, Xian 710061, Peoples R China
基金
中国国家自然科学基金;
关键词
Long noncoding RNA; UCA1; Cancer; Metastasis; Chemoresistance; CELL-CYCLE DISTRIBUTION; BLADDER-CANCER; TUMOR-SUPPRESSOR; MOLECULAR-MECHANISMS; COLORECTAL-CANCER; PROSTATE-CANCER; GASTRIC-CANCER; HEXOKINASE; UCA1; CARCINOMA;
D O I
10.1007/s00432-015-2042-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Urothelial cancer associated 1 (UCA1) is a long noncoding RNA (lncRNA) which has gained more attention in recent years due to its aberrant expression in embryogenesis and a broad range of cancer tissues and cells. Importantly, multiple studies have shown that UCA1 plays oncogenic roles in tumor growth and metastasis, and it may act as a potential biomarker and therapeutic target for human cancers. However, the molecular mechanism of UCA1 in cancer initiation, progression and metastasis remains incompletely understood. Thus, gaining a better understanding of the functional mechanism of UCA1 in cancer onset and progression is of the utmost significance for evaluating the potential application of UCA1. In this review, we discuss UCA1 expression profiling, isoform, expression regulation, biological role and mechanism for UCA1 tumor-promoting effect. We further discuss the potential clinical application of UCA1 as a promising diagnostic biomarker or therapeutic target for human cancers. UCA1 functions as an oncogenic lncRNA in several malignancies, and it might become a potential biomarker or therapeutic target for human cancers.
引用
下载
收藏
页码:1407 / 1419
页数:13
相关论文
共 50 条
  • [41] MALAT1 — a paradigm for long noncoding RNA function in cancer
    Tony Gutschner
    Monika Hämmerle
    Sven Diederichs
    Journal of Molecular Medicine, 2013, 91 : 791 - 801
  • [42] MALAT1- a paradigm for long noncoding RNA function in cancer
    Gutschner, Tony
    Haemmerle, Monika
    Diederichs, Sven
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2013, 91 (07): : 791 - 801
  • [43] Long noncoding RNA associated-competing endogenous RNAs in gastric cancer
    Tian Xia
    Qi Liao
    Xiaoming Jiang
    Yongfu Shao
    Bingxiu Xiao
    Yang Xi
    Junming Guo
    Scientific Reports, 4
  • [44] Long noncoding RNA associated-competing endogenous RNAs in gastric cancer
    Xia, Tian
    Liao, Qi
    Jiang, Xiaoming
    Shao, Yongfu
    Xiao, Bingxiu
    Xi, Yang
    Guo, Junming
    SCIENTIFIC REPORTS, 2014, 4
  • [45] Long noncoding RNA ARSR is associated with a poor prognosis in patients with colorectal cancer
    Li, Ting
    Jin, Xuezhu
    Dong, Jingrong
    Deng, Houbo
    JOURNAL OF GENE MEDICINE, 2020, 22 (10):
  • [46] The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy
    Hao, Qian
    Zhou, Xiang
    CANCER BIOLOGY & MEDICINE, 2022, 19 (02) : 140 - 146
  • [47] The emerging role of long noncoding RNA RMRP in cancer development and targeted therapy
    Qian Hao
    Xiang Zhou
    Cancer Biology & Medicine, 2022, 19 (02) : 140 - 146
  • [48] Colorectal neoplasia differentially expressed: a long noncoding RNA with an imperative role in cancer
    Dai, Meiyu
    Li, Shan
    Qin, Xue
    ONCOTARGETS AND THERAPY, 2018, 11 : 3755 - 3763
  • [49] The Long Noncoding RNA HOTAIR in Breast Cancer: Does Autophagy Play a Role?
    Pawlowska, Elzbieta
    Szczepanska, Joanna
    Blasiak, Janusz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (11)
  • [50] Downregulation of long noncoding RNA B4GALT1-AS1 is associated with breast cancer development
    Samaneh ahvaz
    Mohammad Amini
    Amirhossein Yari
    Behzad Baradaran
    Asiyeh Jebelli
    Ahad Mokhtarzadeh
    Scientific Reports, 14